Role of GENEXpert MTB/RIF in the Diagnosis of Tuberculosis Experience of the Central Laboratory of CHU Hassan II in Fez
Braoul Michkate Braoul Michkate, Raounak El Yaacoubi Raounak El Yaacoubi, Ghita Yahyaoui, Mustapha Mahmoud, Sara Kouara
Journal of medical and dental science research. · 2025-04
Abstract
Introduction Tuberculosis (TB) remains a major infectious disease, causing millions of deaths annually. The GeneXpert MTB/RIF, based on real-time PCR, provides rapid and reliable diagnosis while also detecting rifampicin resistance. Materials and Methods : This article presents the experience of the central laboratory at CHU Hassan II in Fez in diagnosing tuberculosis over a 12-month period, from December 2023 to December 2024. Results Among 507 samples, 65 (12.8%) were TB-positive. The majority were sputum samples (53.8%), followed by cerebrospinal fluid and peritoneal fluid. No rifampicin resistance was detected. Conclusion The GeneXpert MTB/RIF is a high-performance tool with elevated sensitivity, including in extrapulmonary TB. Its implementation enables faster diagnosis and improved patient management.
MeSH terms
- GeneXpert MTB/RIF
- Tuberculosis
- Virology
- Medicine